NUC-1031 in Patients With Advanced Solid Tumours
NCT01621854
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
NUC-1031
Sponsor
Imperial College London
Collaborators
[object Object]